How Reduced S-nitrosylation of TGFβ1 Affects Breast Cancer Signaling
Author Information
Author(s): Letson Joshua, Ren Gang, Zheng Xunzhen, Sweef Osama, Corcino Yalitza Lopes, Furuta Saori
Primary Institution: University of Toledo Health Science Campus
Hypothesis
TGFβ is directly targeted for S-nitrosylation by nitric oxide to suppress its activity.
Conclusion
The study reveals that reduced S-nitrosylation of TGFβ1 increases its binding affinity to the receptor, promoting fibrogenic signaling in breast tissue.
Supporting Evidence
- Pharmacological inhibition of nitric oxide production in mammary glands led to increased TGFβ activity.
- Mutations in TGFβ1 cysteines impaired S-nitrosylation and shifted binding affinity towards the receptor.
- S-nitrosylation-defective mutants showed increased levels of TGFβ signaling molecules.
Takeaway
When a certain chemical in the body is low, a protein called TGFβ1 can become more active, which might lead to problems like cancer.
Methodology
The study involved mutating specific cysteines in TGFβ1 to assess their role in S-nitrosylation and subsequent signaling effects in breast cancer cell lines.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website